Literature DB >> 28827043

Nivolumab-associated nausea and vomiting as an immune adverse event.

Yiwen Shi1, Paul Lin2, Edith Y Ho3, Charles J Nock4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28827043     DOI： 10.1016/j.ejca.2017.07.029

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

Review 1.  Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients.

Authors:  Jordi Remon; Laura Mezquita; Jesús Corral; Noelia Vilariño; Noemi Reguart
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  Upper Gastrointestinal Tract IrAEs: A Case Report About Sintilimab-Induced Acute Erosive Hemorrhagic Gastritis.

Authors:  Qi Ai; Wen Chen; Yonggui Li; Guoqing Li
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

3.  Identification of Prognostic Markers of N6-Methylandenosine-Related Noncoding RNAs in Non-Small-Cell Lung Cancer.

Authors:  Zexin Zhang; Jing Li; Ke Lu; Wenfeng Wu; Ziyi Huang; Chi Zhang; Wei Guo; Jiayin Li; Lizhu Lin
Journal:  J Oncol       Date:  2022-04-01       Impact factor: 4.375
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.